145 related articles for article (PubMed ID: 8275510)
1. Detection of c-Ha-ras oncogene expression in pleural and peritoneal smear effusions by in situ hybridization.
Athanassiadou PP; Veneti SZ; Kyrkou KA; Athanassiades PH
Cancer Detect Prev; 1993; 17(6):585-90. PubMed ID: 8275510
[TBL] [Abstract][Full Text] [Related]
2. Correlation of cytologic examination with ELISA assays for hyaluronan and soluble CD44v6 levels in evaluation of effusions.
Afify A; Lynne LC; Howell L
Diagn Cytopathol; 2007 Feb; 35(2):105-10. PubMed ID: 17230576
[TBL] [Abstract][Full Text] [Related]
3. Malignant mesothelioma: immunohistochemistry and DNA ploidy analysis as methods to differentiate mesothelioma from benign reactive mesothelial cell proliferation and adenocarcinoma in pleural and peritoneal effusions.
Friedman MT; Gentile P; Tarectecan A; Fuchs A
Arch Pathol Lab Med; 1996 Oct; 120(10):959-66. PubMed ID: 12046609
[TBL] [Abstract][Full Text] [Related]
4. The metabolic behaviour of the cellular populations in the pleural or peritoneal effusions from patients with malignant diseases.
Mihăilescu E; Micu D; Cheţa N; Chiriloiu C; Georgescu M; Vilău C
Med Interne; 1986; 24(3):227-33. PubMed ID: 2430328
[TBL] [Abstract][Full Text] [Related]
5. MUC4 is upregulated in ovarian carcinoma effusions and differentiates carcinoma cells from mesothelial cells.
Davidson B; Baekelandt M; Shih IeM
Diagn Cytopathol; 2007 Dec; 35(12):756-60. PubMed ID: 18008338
[TBL] [Abstract][Full Text] [Related]
6. Combination of cytology, fluorescence in situ hybridization for aneuploidy, and reverse-transcriptase polymerase chain reaction for human mammaglobin/mammaglobin B expression improves diagnosis of malignant effusions.
Fiegl M; Haun M; Massoner A; Krugmann J; Müller-Holzner E; Hack R; Hilbe W; Marth C; Duba HC; Gastl G; Grünewald K
J Clin Oncol; 2004 Feb; 22(3):474-83. PubMed ID: 14752070
[TBL] [Abstract][Full Text] [Related]
7. Local immunotherapy with interferon-alpha in metastatic pleural and peritoneal effusions: correlation with immunologic parameters.
Stathopoulos GP; Baxevanis CN; Papadopoulos NG; Zarkadis IK; Papacostas P; Michailakis E; Tsiatas ML; Papamichail M
Anticancer Res; 1996; 16(6B):3855-60. PubMed ID: 9042270
[TBL] [Abstract][Full Text] [Related]
8. Differentiation of mesothelioma from adenocarcinoma in serous effusions: the role of hyaluronic acid and CD44 localization.
Afify AM; Stern R; Michael CW
Diagn Cytopathol; 2005 Mar; 32(3):145-50. PubMed ID: 15690337
[TBL] [Abstract][Full Text] [Related]
9. Primary effusion lymphoma: cytopathologic diagnosis using in situ molecular genetic analysis for human herpesvirus 8.
Wakely PE; Menezes G; Nuovo GJ
Mod Pathol; 2002 Sep; 15(9):944-50. PubMed ID: 12218212
[TBL] [Abstract][Full Text] [Related]
10. Role of immunoperoxidase staining in serous effusions.
Sarker AB; Hoshida Y; Nose S
Bangladesh Med Res Counc Bull; 1993 Aug; 19(2):33-8. PubMed ID: 8161332
[TBL] [Abstract][Full Text] [Related]
11. Carbohydrate antigen expression in primary tumors, metastatic lesions, and serous effusions from patients diagnosed with epithelial ovarian carcinoma: evidence of up-regulated Tn and Sialyl Tn antigen expression in effusions.
Davidson B; Berner A; Nesland JM; Risberg B; Kristensen GB; Tropé CG; Bryne M
Hum Pathol; 2000 Sep; 31(9):1081-7. PubMed ID: 11014575
[TBL] [Abstract][Full Text] [Related]
12. Morphological and cytochemical investigation of human mesothelial cells from pleural and peritoneal effusions: a light and electron microscopy study.
Efrati P; Nir E
Isr J Med Sci; 1976 Jul; 12(7):662-73. PubMed ID: 972021
[TBL] [Abstract][Full Text] [Related]
13. [Contribution of immunocytochemical marking of benign cells to the diagnosis of serous effusions].
Gaulier A; Cava E; Chosia MC; Pore G; Marsan C
Ann Pathol; 1986; 6(4-5):323-8. PubMed ID: 3814272
[TBL] [Abstract][Full Text] [Related]
14. Serous effusions in malignant lymphomas: a review.
Das DK
Diagn Cytopathol; 2006 May; 34(5):335-47. PubMed ID: 16604559
[TBL] [Abstract][Full Text] [Related]
15. The use of CDKN2A deletion as a diagnostic marker for malignant mesothelioma in body cavity effusions.
Illei PB; Ladanyi M; Rusch VW; Zakowski MF
Cancer; 2003 Feb; 99(1):51-6. PubMed ID: 12589646
[TBL] [Abstract][Full Text] [Related]
16. Hyaluronic acid content of effusions as a diagnostic aid for malignant mesothelioma.
Roboz J; Greaves J; Silides D; Chahinian AP; Holland JF
Cancer Res; 1985 Apr; 45(4):1850-4. PubMed ID: 3978644
[TBL] [Abstract][Full Text] [Related]
17. Potential diagnostic value of methylation profile in pleural fluid and serum from cancer patients with pleural effusion.
Benlloch S; Galbis-Caravajal JM; Martín C; Sanchez-Paya J; Rodríguez-Paniagua JM; Romero S; Mafe JJ; Massutí B
Cancer; 2006 Oct; 107(8):1859-65. PubMed ID: 16983705
[TBL] [Abstract][Full Text] [Related]
18. Soluble HLA class I molecules in malignant pleural and peritoneal effusions and its possible role on NK and LAK cytotoxicity.
Amirghofran Z; Sheikhi AK; Kumar PV; Saberi Firouzi M
J Cancer Res Clin Oncol; 2002 Aug; 128(8):443-8. PubMed ID: 12200601
[TBL] [Abstract][Full Text] [Related]
19. [Detection of human telomerase reverse transcriptase mRNA of cells in pleural fluid by two-step in situ hybridization using digoxin-labeled oligonucleotide probes].
Shu J; Sun GY; Liu AP; Liu J
Di Yi Jun Yi Da Xue Xue Bao; 2004 Jul; 24(7):771-4. PubMed ID: 15257899
[TBL] [Abstract][Full Text] [Related]
20. [Clinical significance of CEA mRNA detection in pleural and peritoneal effusions by real-time fluorescent quantitative RT-PCR].
Zhang X; Cao J; Zheng S; Li XF
Zhonghua Wai Ke Za Zhi; 2003 Jun; 41(6):411-3. PubMed ID: 12895345
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
